0001348362-20-000006.txt : 20200513 0001348362-20-000006.hdr.sgml : 20200513 20200513123020 ACCESSION NUMBER: 0001348362-20-000006 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20200513 DATE AS OF CHANGE: 20200513 EFFECTIVENESS DATE: 20200513 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Lexaria Bioscience Corp. CENTRAL INDEX KEY: 0001348362 STANDARD INDUSTRIAL CLASSIFICATION: METAL MINING [1000] IRS NUMBER: 202000871 STATE OF INCORPORATION: NV FISCAL YEAR END: 0831 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-366822 FILM NUMBER: 20871972 BUSINESS ADDRESS: STREET 1: 100 - 740 MCCURDY ROAD CITY: KELOWNA STATE: A1 ZIP: V1X 2P7 BUSINESS PHONE: 250-765-6424 MAIL ADDRESS: STREET 1: 100 - 740 MCCURDY ROAD CITY: KELOWNA STATE: A1 ZIP: V1X 2P7 FORMER COMPANY: FORMER CONFORMED NAME: LEXARIA CORP. DATE OF NAME CHANGE: 20080229 FORMER COMPANY: FORMER CONFORMED NAME: Lexaria Corp. DATE OF NAME CHANGE: 20051229 D 1 primary_doc.xml X0708 D LIVE 0001348362 Lexaria Bioscience Corp. 100 - 740 MCCURDY ROAD KELOWNA A1 BRITISH COLUMBIA, CANADA V1X 2P7 250-765-6424 NEVADA LEXARIA CORP. Lexaria Corp. Corporation true CHRISTOPHER BUNKA 100 - 740 MCCURDY ROAD KELOWNA A1 BRITISH COLUMBIA, CANADA V1X 2P7 Executive Officer Director John Docherty 100 - 740 MCCURDY ROAD KELOWNA A1 BRITISH COLUMBIA, CANADA V1X 2P7 Executive Officer Director Allan Spissinger 100 - 740 MCCURDY ROAD KELOWNA A1 BRITISH COLUMBIA, CANADA V1X 2P7 Executive Officer Nicholas Baxter 100 - 740 MCCURDY ROAD KELOWNA A1 BRITISH COLUMBIA, CANADA V1X 2P7 Director Ted McKechnie 100 - 740 MCCURDY ROAD KELOWNA A1 BRITISH COLUMBIA, CANADA V1X 2P7 Director Brian Quigley 100 - 740 MCCURDY ROAD KELOWNA A1 BRITISH COLUMBIA, CANADA V1X 2P7 Director Other Decline to Disclose 06b false 2020-05-06 false true true true false 0 Bradley Woods & Co. Ltd. 13660 None None 805 Third Avenue, 18th Fl New York NY NEW YORK 10022 CA CALIFORNIA CT CONNECTICUT IL ILLINOIS NY NEW YORK PA PENNSYLVANIA WI WISCONSIN true 2039228 2039228 0 true 1 21 151623 0 In addition to the sales commission,the Company issued to the placement agent and its designees Warrants to purchase up to 649,123 shares of common stock and shall, subject to certain exceptions, pay 8% of the proceeds received from warrant exercises. 0 false Lexaria Bioscience Corp. /s/ Christopher Bunka Christopher Bunka CEO 2020-05-13